postmarket

Magnifying glass copy

TGA Publishes updated MDIR Guide

By Grant Bennett | 31 October 2019
Last week, the Australian regulator, the Therapeutic Goods Administration (TGA) published an updated guidance for Australian Sponsors and Manufacturers for the reporting of adverse events in Australia (Medical device incident...
Gandalf

New Zealand WANDers towards increased device regulation

By Arthur Brandwood | 21 December 2018
If you are WANDering about the title of this blog, yes, it’s a dreadful pun I know – but it’s that time of year. New Zealand’s Medsafe have issued a...
Uncertainty

Risk vs. Benefit FDA guidance gets to grips with uncertainty

By Arthur Brandwood | 27 September 2018
Doing risk management in an uncertain world is why regulatory affairs are as much art as science. Innovators will continue to push the envelope of the possible while regulators will...

Search

Recent Posts

China Medical Device Regulations – Major Updates

Apr 8, 2021

European Medical Devices Regulation (EU MDR) Implementation date is just around the corner

Mar 30, 2021

Technical File Differences Between Medical Devices and IVD Medical Devices

Mar 26, 2021

Taiwan FDA Unique Device Identifier (UDI) Draft Regulation

Mar 8, 2021

Hitting the Accelerator

Mar 4, 2021

Prescription Medicine Pathways

Feb 25, 2021

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA NMPA Pharmaceutical PMA postmarket Reform Registrations regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA TGA regulations